The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTekCapital Regulatory News (TEK)

Share Price Information for TekCapital (TEK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 11.25
Bid: 11.00
Ask: 11.50
Change: 0.25 (2.27%)
Spread: 0.50 (4.545%)
Open: 11.00
High: 12.00
Low: 11.25
Prev. Close: 11.00
TEK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Share Options

16 Jun 2022 09:55

RNS Number : 1317P
Tekcapital plc
16 June 2022
 

 

 

16 June 2022

Tekcapital Plc

("Tekcapital", the "Company" or "the Group")

Grant of Share Options

 

Tekcapital Plc (AIM: TEK, OTCQB: TEKCF), the UK intellectual property investment group focused on creating valuable products from investing in university technologies that can improve quality of life, announces the grant of 1,750,000 share options over new ordinary shares of 0.4 pence each in the Company ("Share Options") to certain employees as detailed below.

 

The Share Options will have an exercise price of 32p which is a 9.25p premium on the 22.75p closing mid-market price on 15 June 2022. The Share Options vest in three equal annual instalments from the date of grant and cannot be exercised until 36 months from the date of grant. The Share Options are subject to performance criteria (the criteria requiring a growth in NAV of the Company at a minimum of 8% per annum) as agreed by the Remuneration Committee. If not exercised the Share Options will lapse 5 years after the date of grant.

Executive

No. of options granted

Existing no. of options

 

Option Type

Total no. of options over Ordinary Shares

Total Options held as a percentage of the Company's issued share capital 

Mr. Max Inglis

700,000

1,300,000

Non-EMI

2,000,000

1.34%

Mr. Konrad Dabrowski

1,050,000

2,125,000

Non-EMI

3,175,000

2.12%

 A total of 1,750,000 of the awarded Share Options are as set out below:

 

Following the issue of the new Share Options, the total number of Ordinary Shares under option is 10,250,000 Ordinary Shares representing 6.85% of the Company's issued share capital.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them are set out below pursuant to the EU Market Abuse regulation.

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

a)

 

Name

1. Max Inglis (General Counsel)

2. Konrad Dabrowski (CFO)

2

 

Reason for the notification

a)

 

Position/status

 

1. General Counsel

2. Chief Financial Officer

b)

 

Initial notification /

Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

 

Name

 

TEKCAPITAL PLC

b)

 

LEI

 

213800GOJTOV19FIFZ85 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of

instrument

 

Identification code

 

Options over Ordinary Shares of 0.4p each

 

 

 

 

ISIN: GB00BKXGY798

 

b)

 

Nature of the transaction

 

Grant of options over ordinary shares

c)

 

Price(s) and volume(s)

 

 

 

Director/PDMR

 Price(s)

Volume(s)

Max Inglis

 

32p

700,000

Konrad Dabrowski 

32p

1,050,000

 

 

 

d)

 

Aggregated information

- Aggregated volume

- Price

 

 

Price(s)

Volume(s)

32p per share

1,750,000

 

e)

 

Date of the transaction

 

15 June 2022

f)

 

Place of the transaction

 

Outside a trading venue

 

 

 

About Tekcapital plc

Tekcapital creates value from investing in new, university-developed discoveries that can enhance people's lives and provides a range of technology transfer services to help organisations evaluate and commercialise new technologies. Tekcapital is quoted on the AIM market of the London Stock Exchange (AIM: symbol TEK) and is headquartered in the UK. For more information, please visit www.tekcapital.com

 

LEI: 213800GOJTOV19FIFZ85

 

For further information, please contact:

 

Tekcapital Plc 

Via Flagstaff

Clifford M. Gross, Ph.D. 

SP Angel Corporate Finance LLP (Nominated Adviser and Broker)

+44 (0) 20 3470 0470 

Richard Morrison / Charlie Bouverat (Corporate Finance)

Abigail Wayne / Rob Rees (Corporate Broking)

Flagstaff Strategic and Investor Communications

+44 (0) 20 7129 1474

Tim Thompson / Andrea Seymour / Fergus Mellon

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHGIGDLBUBDGDL
Date   Source Headline
5th Aug 20193:21 pmRNSHolding(s) in Company - Replacement
2nd Aug 20194:15 pmRNSHolding(s) in Company
1st Aug 201911:35 amRNSHolding(s) in Company
1st Aug 201911:34 amRNSHolding(s) in Company
25th Jul 20197:00 amRNSInvestor Conference Call
22nd Jul 20197:00 amRNSExpansion of Tekcapital services in Mexico
16th Jul 20197:00 amRNSNotice of Investor Conference Call
11th Jul 20197:00 amRNSPlacing to raise £0.75 million
27th Jun 20197:00 amRNSGuident Acquires Additional IP
26th Jun 20197:00 amRNSBelluscura likely to receive FDA clearance in 2019
25th Jun 20197:00 amRNSGuident Acquires Additional IP
24th Jun 20197:00 amRNSSalarius Secures New Order for MicroSalt®
13th Jun 20197:00 amRNSSalarius Secures & Delivers Follow-on Order
14th May 20197:00 amRNSLucyd Launches Loud 2.0 Eyewear Line
3rd May 20197:00 amRNSFlorida Legislature Approves Autonomous Vehicles
29th Apr 20197:00 amRNSGuident Files Additional Patent
24th Apr 20197:00 amRNSPortfolio company, Belluscura plc, raises £500,730
23rd Apr 201911:05 amRNSSecond Price Monitoring Extn
23rd Apr 201911:00 amRNSPrice Monitoring Extension
23rd Apr 20197:00 amRNSSalarius secures first commercial order
5th Apr 20193:12 pmRNSResult of AGM
2nd Apr 20197:00 amRNSStrategic Alliance Agreement with Emprende UP
1st Apr 20197:00 amRNSPortfolio Company Update
25th Mar 20197:00 amRNSPortfolio Company Update
25th Mar 20197:00 amRNSAttendance at UK Investor Show
14th Mar 20197:00 amRNSInvestor conference call
14th Mar 20197:00 amRNSPosting of Annual Report and Notice of AGM
1st Mar 20195:26 pmRNSHolding(s) in Company
26th Feb 20197:00 amRNSUpdate of Research Coverage
26th Feb 20197:00 amRNSNotice of Investor Conference Call
25th Feb 20197:00 amRNSFull Year 2018 Preliminary Results
21st Feb 20197:00 amRNSLucyd Provides Market Update
21st Feb 20197:00 amRNSNotice of Preliminary Results Announcement
19th Feb 20198:52 amRNSBelluscura Files Additional Patent
15th Feb 20193:26 pmRNSHolding(s) in Company
30th Jan 20199:23 amRNSHolding(s) in Company
14th Jan 20197:00 amRNSGuident Ltd Appoints Director
17th Dec 20184:36 pmRNSHolding(s) in Company
12th Dec 20187:00 amRNSUniversity IP webinar
6th Dec 20187:00 amRNSGuident Ltd Appoints Director
3rd Dec 20187:00 amRNSLucyd Signs R Sherman as Chief Brand Officer
26th Nov 20187:00 amRNSMello London
14th Nov 20187:00 amRNSLucyd Launches Affiliate and Reseller Program
8th Nov 201811:34 amRNSHolding(s) in Company
19th Oct 20181:52 pmRNSHolding(s) in Company
18th Oct 20185:25 pmRNSHolding(s) in Company
16th Oct 20185:02 pmRNSHolding(s) in Company
15th Oct 20187:00 amRNSPortfolio Company Update
9th Oct 20187:00 amRNSExecutive Appointment
5th Oct 20187:00 amRNSScience Advisor Appointment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.